Kerala lockdown curbs eased in restricted manner, public transport opens

The local bodies with an average TPR of less than 8 percent will have limited restrictions whereas there will be partial lockdown in places with 8-20 percent TPR, full lockdown for 20-30 percent TPR and triple lockdown in areas with TPR above 30 percent.

PTI

June 17, 2021 / 14:45 IST

Kerala CM Pinarayi Vijayan

After 40 days of COVID-19 induced lockdown, Kerala on Thursday limped back to normal as the government eased the curbs allowing shops to open in a restricted manner and permitting public transport on a limited basis.

In the major towns, where the Test Positivity rate (TPR) was less, people could be seen venturing out as the state was under lockdown since May 8.

The chief minister had earlier said that there will be relaxation on the curbs in the state based on the average weekly TPR in Local Self Government bodies.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

The state-run beverages outlets witnessed rush in most of the places on Thursday, but tipplers strictly followed the social distancing norm and other COVID-19 health protocols.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show